COMMUNIQUÉS West-GlobeNewswire

Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board
14/06/2018
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSXV: PRN) (OTCQX:PRFMF) is pleased to announce the results of the votes on the matters considered at its Annual Meeting [...]
Reata Pharmaceuticals, Inc. Secures $125 Million Term Loan Facility
14/06/2018
IRVING, Texas, June 14, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced that it entered into an amended and [...]
Transparency notification
14/06/2018
Mechelen, Belgium; 14 June 2018; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]
Transparency notification pursuant to Article 14 of the Law of May 2, 2007
14/06/2018
REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - June 14, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
Kiniksa Pharmaceuticals to Present at the JMP Securities 2018 Life Sciences Conference
14/06/2018
HAMILTON, Bermuda, June 14, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA) announced today that it will be presenting at the JMP Securities 2018 Life Sciences Conference on Thursday, June 21 st , [...]
AGTC Announces Expansion of Clinical and Regulatory Leadership Teams
14/06/2018
20+ Year Medical Affairs and Ophthalmology Veteran, Lanita C. Scott, M.D., Appointed as Vice President of Clinical Research and Medical Affairs Karen M. Carroll, RN, Named Vice President of Clinical Development [...]
Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
14/06/2018
CALGARY, Alberta, June 14, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has received confirmation from the U.S. Food and Drug Administration (“FDA”) that [...]
Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
14/06/2018
NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the recommendations of the [...]
Real Energy Sustainability Discussed in the Journal of American Physicians and Surgeons
14/06/2018
TUCSON, Ariz., June 14, 2018 (GLOBE NEWSWIRE) -- The drive for energy sustainability is becoming a political weapon to block progress, rather than an inspiration for a steady process of prudent conservation, writes Paul [...]
DIAXONHIT DEVIENT EUROBIO SCIENTIFIC : Changement de nom adopté à l'Assemblée Générale Annuelle
14/06/2018
DIAXONHIT DEVIENT EUROBIO SCIENTIFIC Changement de nom adopté à l'Assemblée Générale Annuelle Les actionnaires ont également adopté toutes les résolutions à titre ordinaire et à titre extraordinaire agréées par le [...]
Solon Eiendom ASA : Primary insider notification
14/06/2018
(Oslo, Norway, 14 June 2018) Reference is made to Solon Eiendom ASA's (the "Company") prospectus dated 16 May 2018 (the "Prospectus") for inter alia the subsequent offering (the "Subsequent Offering") of up to 396,040 [...]
Orion Biotechnology Canada Acquires K2Biomedical
14/06/2018
OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medicines, today announced the acquisition of K2Biomedical, a specialty pharmaceutical research company based in Cracow, [...]
Tivity Health Adds Sara J. Finley and Beth M. Jacob to Board of Directors
14/06/2018
NASHVILLE, Tenn., June 14, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ:TVTY) today announced that it has added two new members to its Board of Directors. Sara J. Finley, Principal of Threshold Corporate [...]
Rafael Pharmaceuticals to Present New Data Validating Efficacy and Tolerability of CPI-613 in Treating Acute Myeloid Leukemia at the 23rd Congress of the European Hematology Association
14/06/2018
Newark, NJ, June 14, 2018 (GLOBE NEWSWIRE) -- CPI-613 is Rafael Pharmaceuticals' lead drug candidate, a first-in-class anticancer compound designed to disrupt the altered energy production pathways in cancer cells by [...]
Rexahn Announces Adjournment of Annual Meeting of Shareholders until Wednesday, June 27, 2018
14/06/2018
Three of four proposals pass with shareholder approval Annual Meeting adjourned solely with respect to Proposal 3 – approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase [...]
Sienna Biopharmaceuticals to Present at JMP Securities Life Science Conference
14/06/2018
WESTLAKE VILLAGE, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of Sienna [...]
Kane Biotech to Present at The MicroCap Conference in Toronto
14/06/2018
Conference Held June 21 Featuring Attractive Companies Across All Sectors WINNIPEG, Manitoba, June 14, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is [...]
Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound
14/06/2018
SCAN Clinical Trial Results Intended to Support CPT Code Application for Incremental Diagnostic Reimbursement REDWOOD CITY, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of [...]
OpGen Modifies Terms of Debt with Merck Global Health Innovation Fund
14/06/2018
GAITHERSBERG, Md., June 14, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has negotiated modifications related to its $1,000,000 Second Amended and Restated Senior Secured Promissory Note ( [...]

Pages